83.1. NeoLongus| Link| Bookmark|
December 17, 2021 11:45:41 AM
IPO Mentor (700+ Posts, 300+ Likes)
Bit shy of reviews Sir since I prefer thinking long term but forum visitors prefer perspectives for listing day gains/losses. Since you''ve specifically asked, I must tell you that I''m completely avoiding this even though I''ve capacity for some HNI/Retail lots. Pricing is far from reasonable though its a decent company with a decent business but not so great cash flows. 50x PE for FY21 and 80x for FY22 is not inspiring confidence for me. Also, the small size makes it prone to manipulation in the short term which I''m not ready to live with though Sigachi in the same scenario was very much liked by me due its strong business and respectable valuation.
Again, the opinion is for those who think beyond GMP and listing gains and only for the long term. Keep minting!
@ K.Atar Apply for with lower no of appl and lower expectation. There is some risk but may prove to be a hidden gem as it transpires to me for listing only. Khela hobe ipo. Better get it with UPI, you will get two days time to rethink.
83.3. K.Atar| Link| Bookmark|
December 17, 2021 12:33:56 PM
IPO Guru (1000+ Posts, 700+ Likes)
@ NeoLongus Sir, Thanks for the frank review, you are one of the few guys whose clear cut approach i admire
@ Asoke Sir, Thanks for crystal clear advise, you say big things in few words. A quality - only few possess.
@Neolongus Sir can sigachi reach its listing price ever?Bought just a few quantity in pre open@570.Trapped since then.Not thinking about averaging right now because of poor market sentiment and cartrade saga is also in my mind.Have you got allotment in sigachi or bought in pre open?Are you still holding it?For long term should I buy mapmyindia in pre open on listing day?
@Ronnie - Please don''t call me Sir. As for your queries:
Sigachi: At current price of about 400, its quite fully priced from a PE basis. I didn''t get Sigachi allotment in any of my Retail accounts, for HNI I didn''t have funds to apply and in pre-open, I felt that the price of 570 was way above my comfort zone. If I were you, I would sit tight and not do anything for a few years if the exposure I carry to the stock is less than 5% of my overall portfolio since its fundamentally a strong company. If the exposure is significant then I''d like to gradually reduce - I don''t see 570 as the price at which it will settle anytime soon because there will always be a lot of selling pressure at any time when it crosses 500 because of the UC''s that took it from below 500 to 530 odd and then the circuit saga broke. However, you will get opportunities during a buoyant market to minimize your loss and exit. Also, if pharma comes back as the flavor of the market and if it performs a little ahead of its past performance then 570 will be easily approached but I think the chances of this are rather slim.
Mapmyindia is a great company but currently there is too much excitement around it and at the issue price + GMP, I believe the upside is very limited for a long term buy. I would wait for meaningful corrections and price settlement and buy from secondary markets on a bad day but not on listing day.
As always, I reserve the right to be wrong and I hope that I am wrong about Sigachi so that you can meaningfully recover your loss and be in profits, soon. Keep minting!
Sure Ronnie - Briefly, both Supriya and CMS are excellent buys at the offered price and I would apply as Retail and/or HNI in both (funds permitting and if HNI x is not obscene). Supriya has an evergreen business model (I burnt my hands in GLS but I still feel good about Supriya) but CMS has significant concerns around its long term sustainability due to electronic payments etc even though existing business is a cash cow (cash circulation will not disappear in a hurry from India or even the western world). Will certainly try to share a more detailed perspective but have a busy weekend. As always, this opinion is only from a long term holding perspective and I reserve the right to be wrong! Keep minting!
At the last moment, I withdraw my application last time. this will also go on negative Coz No QIB interest & talk abt HNI they buy to book the profit only without any sentimental they book the loos or profit. so all relailer best of Luck
The reason for high retail subscription is, all money by HNI is gone in other IPOs and thus even HNI''s are applying in retail category as funds are limited with them.
Main reason is very small IPO size of 125CR. It is bound to get such numbers given the retail awareness. If market sentiment was not bad then it could pass 100 also.
The retail money floating for IPO is, for Bad IPOs(expecting discount listing) 500 Cr, Average IPO 2000 Cr and for Good IPOs (Famous ones with 100% GMP) 6000 Cr. Here in this case the allocation for retail is 12 Cr. You can now judge how many times it might oversubscribe.
The Crow Verdict: Personally, I don''t have much faith in the sealants and adhesives business. It''s the same outlook I have for real estate. That is why after studying Pidilite Industries for 2 months in the hope to accumulate it for my long-term portfolio I dropped it completely. That is when HP Adhesives arrives with this small issue with a business model that hopes to compete with the 65%+ market share of Pidilite. I am not against value companies, mind you, but I have zero confidence in HP, its business model, or its valuation in this highly competitive industry where brand matters.
A critical thing to note here is that you cannot compare HP to a mammoth industry leader like Pidilite. Fevicol MR, Dr Fixit, M-Seal are household names today because of Pidilite''s aggressive marketing and king-like presence. But for the benefit of doubt, HP started way back in 1987 as a scattered partnership, then incorporated in 2019, and finally turned public limited in July this year. All of this increases my anxiety regarding this issue where I am asked to put my hard-earned money. So I have to double-verify and give more heed to my own speculation.
Retail is already 55%+ (not saying much as retail is 10% in this very small issue where anchor mopped up ~30%) so I don''t think retailers need any advise. But, being a tadpole in a pond that has Pidilite as frog, the T2T listing, a measly post-IPO mcap of 500 crore (Sonal and Nikhil are at 5 and 300 crore resp.; Pidilite at 1.2 lakh crore), flat asking price, and overall negative sentiment on Chittorgarh (keep in mind the 1 Avoid rating) all compel me to avoid this issue.
Had it not been T2T, I would have considered subscription ratings to make a decision. But I don''t want to take the chance here as if I get allotment, and it goes LC, I will be stuck like a fixture joined using the very sealant that HP produces. The 90% fresh issue should make me happy but it isn''t. This is no Sigachi or Paras or Latent. Small issues without GMP can be dangerous. Avoid.
I personally differ from your views on Pidilit. I am holding 1000 shares @ 300 and not going to sell it. It is a multibegger stock. It''s products are for each age group like favicol for child''s, many products for young people''s and at the end product like Dr fixit for old people''s.
79.9. snipperRaj| Link| Bookmark|
December 17, 2021 1:45:05 PM
Top Contributor (300+ Posts, 200+ Likes)
@Crow..awesome analysis and write up...thanks n cheers
To each, her own. But, loved your write-up, Crow. "Stuck like a fixture joined using the very sealant that HP produces" takes the cake in my books. :-) And yes, if you blog, please share the link. Would be a fantastic read!
Thanks for the support everyone. QIB and total subscription didn''t cross 30x, so red flags are 8 out of 13. A wicked subscription I would say. Might surprise on listing.
@J K SINGH, apologies. Some issues are harder to explain but I will try to be concise from now on.
@colcol, T2T listing means Trade to Trade. It''s a type of listing on BSE/NSE where you cannot square off or day trade on the counter. You have to mandatorily engage in delivery. This is to prevent speculation and is mostly related to small issues like this. Even Sigachi, Exxaro Tiles, etc. listed as T2T. Read up more on Chittorgarh. The problem with this you cannot exit if the scrip goes south.
@RAJESH, at 300 I would lap it up, trust me. But at 2,000+, it is expensive for me especially in a situation where I don''t like the business.
I do have a blog guys but since I am anonymous here I would like to keep it that way. Let''s make money together safely.
People got money released from CE, but haven''t applied in this IPO. HNI community is giving a skip to this. QIB is still worse. Retail as usual jumped in for listing gains. Lets see the verdict on listing day. Happy Weekend folks.
Dear Chittorgarh Team, There is more clarity if one more column of reserved % quota will add with subscription figure. Category Subscription (times)
QIB Reserved Quota 1.01 NII % 9.54 Retail % 72.19 Total % 16.28
73. dpcdsl| Link| Bookmark|
December 17, 2021 2:10:03 PM
Top Contributor (400+ Posts, 200+ Likes)
Now even after 3 pm QIB and NII figures not improved, it means HP is not good for subscription. Retailers in hurry to capture but looking into Rate Gain listing wherein QIB and NII subscribed more than retailers at 15% discount is really a cause of concern.
What "Singhania G" says on this :- After seeing fundamentals it''s just came in profit in last year. Though business is good but this co. is fighting with a giant Pedilite which is brand stablished name( we use fevicol word for good glue, m seal & Dr. fixit just like maggi). One this is good for this co. is "if you aim the moon you may hit a star". So growth is there for long term.
For listing Gains : First of all i don''t think it can give 100% gain on listing as compare to Supriya. As Subscription also says that QIB is doing only their work of QUOTA not interested in buying this. NIIs are investing from their self funded. That means they also think not that much listing gain. Rest Retailers most of those thinks this is small ticket ipo will give surely returns, though in case of retail chances are too much high of not getting whereas in Supriya it will be best for Chances of allotment and listing gains prospective........
So for retailers who have limited fund should avoid as you have better option than this of getting listing gain & allotment chances too..........still have enough funds that will stay in bank then apply
68. R R Patel| Link| Bookmark|
December 17, 2021 1:42:02 PM
IPO Mentor (800+ Posts, 3400+ Likes)
I’m not applying as very small issue like SME platform of 125 crores n retail only 10% (9194 lots) so 1-2% chances of allotment, no grey activity, no growth in revenue or PAT, in such products brand matters so not looking good although it may give listing gain but operator game may also happen. It may go either side in circuit filter after listing. So I’m not interested. I’ll apply Supriya Life
67. Learner SK| Link| Bookmark|
December 17, 2021 12:33:04 PM
Top Contributor (1000+ Posts, 200+ Likes)
Pros - Small size IPO. Will be operators play for sure. So one, if allotted, can exist during initial hours with profit.
Cons: RII may cross 60X. So we little chance to get.
Hero or Zero we won''t know right now, but one thing is sure.. This company will hit Circuit, either Upper or Lower (or both on different days) ! We will know that after listing